Summary
For Year 2026-27, Modern Diagnostic & Research Centre reports the following shareholding: Total Promoters at 72.85%, Mutual Fund at 0%, Insurance at 0.12%, Foreign Institutional Investors at 0.03%, Domestic Institutional Investors at 15.36%, and Retail at 11.64%. This breakdown provides a quick snapshot of ownership distribution for Modern Diagnostic & Research Centre in 2026-27.
Modern Diagnostic & Research Centre FAQs
As of 05-2026, the promoter shareholding in Modern Diagnostic & Research Centre stands at 72.85% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Modern Diagnostic & Research Centre is 0.03% and 15.36% respectively.
The retail shareholding of the Modern Diagnostic & Research Centre is 11.64%.
Changes in shareholding patterns of Modern Diagnostic & Research Centre can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Modern Diagnostic & Research Centre are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Modern Diagnostic & Research Centre Associated Pages
- Modern Diagnostic & Research Centre Share Price
- Modern Diagnostic & Research Centre Share Price chart
- Modern Diagnostic & Research Centre Fundamental Analysis
- Modern Diagnostic & Research Centre Technical Analysis
- Modern Diagnostic & Research Centre Peer Comparison
- Modern Diagnostic & Research Centre Share Price History
- Modern Diagnostic & Research Centre Board of Directors
